ICD10 code of Lysosomal acid lipase deficiency and ICD9 code

Lysosomal acid lipase deficiency (LAL deficiency) is officially classified under the ICD-10-CM code E75.5 (Other lipid storage disorders). While the older ICD-9-CM system categorized it under 272.7 (Lipidoses), clinicians now exclusively utilize the ICD-10 system for diagnostic coding and insurance documentation.

What is the clinical significance of the LAL deficiency ICD codes?

The transition from ICD-9 to ICD-10 provided a more specific framework for classifying Lysosomal acid lipase deficiency, which is a rare, multisystemic, and progressive metabolic disorder. Accurate coding is essential for medical records, as Lysosomal acid lipase deficiency results from a deficiency of the enzyme lysosomal acid lipase (LAL), leading to the accumulation of cholesteryl esters and triglycerides in the liver, spleen, and intestinal walls. By using the correct ICD-10 code (E75.5), physicians ensure that patients receive appropriate clinical management and facilitate access to specialized therapies, such as enzyme replacement therapy (sebelipase alfa), which is indicated for this condition.

How does the clinical presentation of Lysosomal acid lipase deficiency vary?

Because Lysosomal acid lipase deficiency encompasses a broad spectrum of severity, the clinical manifestations often dictate the urgency of diagnostic coding. The condition historically included two recognized phenotypes, though they are now viewed as a continuum:

• Wolman disease: The most severe, early-onset form typically presenting in infancy with failure to thrive, hepatosplenomegaly, and adrenal calcification.


• Cholesteryl Ester Storage Disease (CESD): A milder, later-onset form that may present in childhood or adulthood with elevated transaminases, hepatomegaly, and dyslipidemia.

Is Lysosomal acid lipase deficiency hereditary?

Yes, Lysosomal acid lipase deficiency is an autosomal recessive genetic disorder caused by mutations in the LIPA gene. This means that an individual must inherit two copies of the mutated gene—one from each carrier parent—to manifest the disease. Genetic counseling is strongly recommended for families affected by Lysosomal acid lipase deficiency to understand the 25% recurrence risk for each pregnancy and to facilitate cascade screening for siblings and other relatives who may be asymptomatic carriers.

How is the diagnosis of Lysosomal acid lipase deficiency confirmed?

Beyond the use of ICD-10 coding for administrative purposes, a definitive diagnosis of Lysosomal acid lipase deficiency is established through specific biochemical and molecular testing. The following diagnostic steps are standard practice:

1. Enzyme Activity Assay: Measuring LAL enzyme activity in dried blood spots (DBS), leukocytes, or fibroblasts to confirm a significant reduction or absence of function.


2. Molecular Genetic Testing: Sequencing the LIPA gene to identify pathogenic variants that confirm the diagnosis.


3. Liver Biopsy: Occasionally performed to assess the extent of lipid accumulation and fibrosis, though non-invasive genetic and biochemical tests are now the preferred first-line diagnostic tools.

At DiseaseMaps.org, we have seen members of our community navigate these diagnostic hurdles. Connecting with the 5 members currently mapped with Lysosomal acid lipase deficiency can provide peer-based emotional support as you manage the complexities of this rare diagnosis.

Next steps

• Consult with a metabolic specialist or a hepatologist who has experience managing lysosomal storage disorders.


• Request a referral to a certified genetic counselor to discuss family planning and carrier testing for at-risk relatives.


• Join the DiseaseMaps.org community to share experiences and connect with others living with this rare condition.


• Verify that your electronic health record reflects the correct ICD-10 code (E75.5) to ensure continuity of care and insurance coverage.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Lysosomal acid lipase deficiency (ORPHA:79268)


• NIH GARD: Genetic and Rare Diseases Information Center: Lysosomal acid lipase deficiency


• OMIM: Online Mendelian Inheritance in Man: Lysosomal acid lipase deficiency (Entry #278000)


• International Classification of Diseases (ICD-10-CM): Centers for Medicare & Medicaid Services (CMS) coding guidelines